Vimarsana
Biggest News Aggregation in the World

Intas Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intas Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intas Pharma Today - Breaking & Trending Today

ChrysCapital closes its continuation fund at $700 million - Vimarsana News

ChrysCapital closes its continuation fund at $700 million

The new fund has acquired a stake in National Stock Exchange of India Ltd from ChrysCapital's Fund VI

Chrys Cap, Kedaara prepare their biggest funds ever - Vimarsana News

Chrys Cap, Kedaara prepare their biggest funds ever

While ChrysCapital aims to raise $2-2.2 billion for its tenth fund, Kedaara is in the market for its fourth fund of $1-1.5 billion

Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds - Vimarsana News

Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds

Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors, having raised capital from ICICI Venture way back in 1996 ......

Last mainboard listing of 2023 | Innova Captab shares close 21% higher on debut - Vimarsana News

Last mainboard listing of 2023 | Innova Captab shares close 21% higher on debut

Innova Captab | The listing was far lower than analysts' expectations and the grey market premium. The expected listing premium was around 25 percent over the issue price.

Usfda: USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant - Vimarsana News

Usfda: USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant

India Business News: US health regulator issues warning letter to Intas Pharmaceuticals CEO and MD Nimish Chudgar for manufacturing lapses and violation of CGMP regulation